Literature DB >> 15370121

Local recurrence of melanoma.

P J Heenan1.   

Abstract

Local recurrence (LR) of cutaneous malignant melanoma (CMM) is a controversial issue, especially in regard to recommendations for margins of excision of primary CMM. Factual evidence in support of the belief that wider margins of excision decrease the risk of local recurrence is meagre, but recommendations for adjusting margins of excision according to tumour thickness are still presented. The histological features of LR indicate that two mechanisms are involved: (1) persistent growth of incompletely excised primary melanoma, and (2) local metastasis. The second group comprises the most common form of LR and is associated with a poor prognosis, indicating that it is a manifestation of systemic disease. The morphological features and the prognostic implications of LR indicate that many are due to haematogenous rather than lymphatic metastasis alone and, therefore, are not preventable by wider excisions beyond complete excision of the primary tumour itself. The concept that most LRs are metastases is consistent with the failure of wide margins of excision to prevent LR. The higher risk of LR associated with greater tumour thickness is associated with the increased risk of metastasis from the thicker tumours, not with the extent of excision. The resolution of the controversy regarding the primary surgical treatment of CMM depends on the recognition by pathologists and clinicians alike that the two types of LR have diagnostic microscopic features and that they have entirely different implications for prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15370121     DOI: 10.1080/00313020412331282690

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  Histopathologic excision margin affects local recurrence rate: Analysis of 2681 patients with melanoma < or = 2 mm thick.

Authors:  Peter J Heenan
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

2.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

3.  Desmoplastic melanoma: report of 5 cases.

Authors:  A M Manganoni; C Farisoglio; S Bassissi; D Braga; F Facchetti; M Ungari; P G Calzavara-Pinton
Journal:  Dermatol Res Pract       Date:  2009-11-30

4.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

5.  Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma.

Authors:  Alexandra S Berghe; Gheorghe Cobzac; George Dindelegan; Simona C Șenilă; Corina I Baican; Carolina M Solomon; Liliana Rogojan; Daniel C Leucuța; Tudor C Drugan; Sorana D Bolboacă
Journal:  Exp Ther Med       Date:  2021-05-05       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.